UREA

UREA was reported 2212 times

UREA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMYLOID ARTHROPATHY 15 0.2143
1 DIFFUSION-WEIGHTED BRAIN MRI ABNORMAL 2 0.0741
2 ANTI-ERYTHROPOIETIN ANTIBODY NEGATIVE 5 0.0549
3 BLADDER TRANSITIONAL CELL CARCINOMA RECURRENT 4 0.0392
4 PRODUCT ADMINISTRATION ISSUE 7 0.0335
5 DEPRESCRIBING ERROR 2 0.0308
6 MYELOBLAST COUNT INCREASED 2 0.0260
7 BILIRUBIN CONJUGATED ABNORMAL 2 0.0180
8 OVERLAP SYNDROME 9 0.0129
9 INFECTIVE GLOSSITIS 2 0.0128
10 PITYRIASIS RUBRA PILARIS 3 0.0126
11 HYDROTHORAX 10 0.0120
12 ANASTOMOTIC LEAK 6 0.0086
13 ICHTHYOSIS 2 0.0079
14 DUMPING SYNDROME 2 0.0076
15 UTERINE MASS 3 0.0073
16 NAIL DYSTROPHY 4 0.0071
17 VASCULITIC RASH 5 0.0065
18 C-REACTIVE PROTEIN 6 0.0065
19 PULMONARY PAIN 18 0.0062
20 ANAL ULCER 5 0.0061
21 BILIARY CIRRHOSIS PRIMARY 2 0.0058
22 HEPATITIS B CORE ANTIBODY POSITIVE 2 0.0053
23 NEOPLASM SKIN 8 0.0051
24 LIBIDO INCREASED 10 0.0049
25 OTITIS MEDIA CHRONIC 2 0.0048
26 LUPUS VULGARIS 6 0.0048
27 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
28 OESOPHAGEAL DILATATION 2 0.0045
29 HOMELESS 2 0.0045
30 DEEP VEIN THROMBOSIS POSTOPERATIVE 9 0.0045
31 IMMUNE-MEDIATED HYPOPHYSITIS 2 0.0044
32 MECHANICAL URTICARIA 2 0.0043
33 ECZEMA ASTEATOTIC 2 0.0042
34 CALCULUS URETERIC 3 0.0041
35 PALMOPLANTAR KERATODERMA 3 0.0041
36 ELECTROLYTE DEPLETION 2 0.0041
37 GENITAL ERYTHEMA 2 0.0040
38 INTERTRIGO 2 0.0037
39 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 85 0.0036
40 PERIORBITAL HAEMATOMA 3 0.0036
41 PSEUDOMEMBRANOUS COLITIS 8 0.0036
42 EJECTION FRACTION 2 0.0034
43 BILE DUCT STENOSIS 4 0.0033
44 DYSMETRIA 2 0.0033
45 HYPERKERATOSIS 18 0.0033
46 METASTASES TO ADRENALS 3 0.0033
47 BLOOD BILIRUBIN ABNORMAL 4 0.0031
48 INTRACRANIAL HYPOTENSION 2 0.0031
49 CHONDROCALCINOSIS 2 0.0031
50 ENCEPHALITIS AUTOIMMUNE 4 0.0030
51 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 2 0.0030
52 CHANGE OF BOWEL HABIT 6 0.0029
53 RETINITIS 5 0.0029
54 MONOCYTE PERCENTAGE INCREASED 2 0.0028
55 SWOLLEN JOINT COUNT INCREASED 9 0.0028
56 ALPHA 1 FOETOPROTEIN INCREASED 2 0.0028
57 GALLBLADDER ENLARGEMENT 3 0.0028
58 BLADDER DILATATION 3 0.0028
59 LIP EROSION 2 0.0027
60 BLOOD LOSS ANAEMIA 6 0.0026
61 BRONCHITIS BACTERIAL 2 0.0026
62 BASOPHIL COUNT INCREASED 2 0.0026
63 COMPLICATION OF PREGNANCY 2 0.0026
64 INCISION SITE PAIN 3 0.0026
65 HAEMOPERITONEUM 2 0.0025
66 IMMUNE-MEDIATED HEPATITIS 5 0.0024
67 HYPERPARATHYROIDISM 5 0.0024
68 CANCER PAIN 6 0.0023
69 IMMUNE-MEDIATED ENTEROCOLITIS 8 0.0022
70 ENTEROCOLITIS INFECTIOUS 2 0.0022
71 INCISIONAL HERNIA 3 0.0022
72 ESCHERICHIA BACTERAEMIA 5 0.0021
73 HYPOPROTEINAEMIA 4 0.0021
74 FOREIGN BODY IN EYE 2 0.0021
75 LYMPHADENECTOMY 2 0.0020
76 RHEUMATIC FEVER 9 0.0020
77 CHOLANGIOCARCINOMA 3 0.0020
78 DERMATITIS EXFOLIATIVE GENERALISED 7 0.0020
79 HYPOPHYSITIS 4 0.0020
80 ADHESION 3 0.0020
81 EPICONDYLITIS 3 0.0020
82 DYSAESTHESIA 6 0.0020
83 METASTASES TO SKIN 2 0.0019
84 ENTEROCOLITIS 11 0.0019
85 RHEUMATOID FACTOR POSITIVE 11 0.0019
86 PHARYNGEAL PARAESTHESIA 3 0.0019
87 HYPERCHOLESTEROLAEMIA 18 0.0019
88 CARDIAC AMYLOIDOSIS 2 0.0018
89 AORTIC DILATATION 2 0.0018
90 GASTRIC DILATATION 3 0.0018
91 DERMATITIS EXFOLIATIVE 9 0.0018
92 GASTROINTESTINAL ULCER HAEMORRHAGE 2 0.0018
93 CARBON DIOXIDE DECREASED 2 0.0017
94 OTORRHOEA 3 0.0017
95 GROIN ABSCESS 2 0.0017
96 BONE EROSION 6 0.0017
97 UTERINE POLYP 3 0.0017
98 DYSPLASIA 2 0.0017
99 THYROIDITIS 5 0.0017
100 FURUNCLE 13 0.0016
101 ESSENTIAL HYPERTENSION 3 0.0016
102 ORAL MUCOSA EROSION 2 0.0016
103 SMALL INTESTINAL PERFORATION 3 0.0016
104 MALLORY-WEISS SYNDROME 2 0.0016
105 LIP HAEMORRHAGE 2 0.0016
106 ADRENAL INSUFFICIENCY 19 0.0016
107 OBSTRUCTION GASTRIC 2 0.0016
108 LIVER ABSCESS 5 0.0015
109 DERMATITIS BULLOUS 11 0.0015
110 SKIN PAPILLOMA 6 0.0015
111 ULCER HAEMORRHAGE 10 0.0015
112 NIPPLE PAIN 3 0.0015
113 HELICOBACTER INFECTION 15 0.0015
114 MENINGITIS VIRAL 2 0.0015
115 PEMPHIGOID 11 0.0015
116 NAIL INFECTION 2 0.0014
117 MYOPATHY 12 0.0014
118 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 9 0.0014
119 ONYCHOMYCOSIS 6 0.0014
120 HYPOMANIA 5 0.0014
121 RHINITIS ALLERGIC 6 0.0013
122 ABNORMAL FAECES 11 0.0013
123 PROTEIN TOTAL DECREASED 5 0.0013
124 DISLOCATION OF VERTEBRA 3 0.0013
125 PERFORMANCE STATUS DECREASED 6 0.0013
126 BILIRUBIN CONJUGATED INCREASED 3 0.0013
127 BLOOD CREATININE DECREASED 4 0.0013
128 OPHTHALMOPLEGIA 2 0.0013
129 URINARY TRACT OBSTRUCTION 3 0.0013
130 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 9 0.0013
131 NASAL ULCER 2 0.0013
132 SKIN TOXICITY 7 0.0012
133 DUODENAL ULCER PERFORATION 9 0.0012
134 OBESITY 19 0.0012
135 METASTASES TO SPINE 4 0.0012
136 METASTASES TO PERITONEUM 3 0.0012
137 HEPATIC ENCEPHALOPATHY 11 0.0012
138 BLOOD AMYLASE INCREASED 2 0.0012
139 AORTIC ARTERIOSCLEROSIS 3 0.0012
140 PHYSICAL DECONDITIONING 3 0.0012
141 PUSTULAR PSORIASIS 4 0.0012
142 CERVICAL SPINAL STENOSIS 2 0.0012
143 ACTINIC KERATOSIS 3 0.0012
144 LARYNGOSPASM 3 0.0011
145 MAJOR DEPRESSION 8 0.0011
146 MEAN CELL HAEMOGLOBIN DECREASED 2 0.0011
147 C-REACTIVE PROTEIN ABNORMAL 7 0.0011
148 MUSCLE INJURY 9 0.0011
149 OTOTOXICITY 2 0.0011
150 NASAL OBSTRUCTION 2 0.0011
151 BLOOD IRON INCREASED 2 0.0011
152 ANTIPSYCHOTIC DRUG LEVEL INCREASED 3 0.0011
153 HEPATOCELLULAR CARCINOMA 8 0.0011
154 GENERALISED OEDEMA 13 0.0010
155 GASTROINTESTINAL TOXICITY 5 0.0010
156 ARTERIAL THROMBOSIS 2 0.0010
157 AUTOIMMUNE DISORDER 10 0.0010
158 NECK INJURY 3 0.0010
159 HYPERAEMIA 2 0.0010
160 ODYNOPHAGIA 6 0.0010
161 ANORECTAL DISORDER 2 0.0010
162 REBOUND ACID HYPERSECRETION 3 0.0010
163 PENILE PAIN 3 0.0010
164 PATHOLOGICAL FRACTURE 5 0.0010
165 DYSCHEZIA 3 0.0010
166 DERMATITIS PSORIASIFORM 2 0.0010
167 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 2 0.0010
168 SECOND PRIMARY MALIGNANCY 8 0.0010
169 BODY TEMPERATURE FLUCTUATION 2 0.0010
170 MUSCLE ATROPHY 12 0.0009
171 MUSCLE FATIGUE 4 0.0009
172 ACUTE MYELOID LEUKAEMIA RECURRENT 2 0.0009
173 HYPERPHOSPHATAEMIA 2 0.0009
174 HORDEOLUM 4 0.0009
175 CALCINOSIS 2 0.0009
176 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2 0.0009
177 WOUND DEHISCENCE 3 0.0009
178 LIP DRY 8 0.0009
179 PEMPHIGUS 11 0.0009
180 PRESCRIBED OVERDOSE 17 0.0009
181 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 9 0.0009
182 LICHENOID KERATOSIS 2 0.0009
183 LEFT VENTRICULAR FAILURE 3 0.0009
184 DROOLING 6 0.0009
185 MOUTH SWELLING 5 0.0009
186 NEPHROGENIC ANAEMIA 4 0.0009
187 HYPOMAGNESAEMIA 12 0.0009
188 FOLLICULITIS 9 0.0009
189 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
190 INGROWING NAIL 2 0.0008
191 SKIN ABRASION 4 0.0008
192 GLOSSITIS 3 0.0008
193 TASTE DISORDER 17 0.0008
194 GAIT INABILITY 28 0.0008
195 SCLERODERMA 3 0.0008
196 END STAGE RENAL DISEASE 15 0.0008
197 HAEMATOLOGICAL INFECTION 2 0.0008
198 SCIATICA 13 0.0008
199 LOWER GASTROINTESTINAL HAEMORRHAGE 6 0.0008
200 KNEE ARTHROPLASTY 17 0.0008
201 PRE-EXISTING CONDITION IMPROVED 5 0.0008
202 HYPERPARATHYROIDISM SECONDARY 2 0.0008
203 C-REACTIVE PROTEIN INCREASED 29 0.0008
204 OSTEITIS 2 0.0008
205 HYPOCALCAEMIA 15 0.0008
206 DYSLIPIDAEMIA 4 0.0008
207 APPENDICITIS PERFORATED 2 0.0008
208 THYROID MASS 3 0.0008
209 MEAN CELL VOLUME INCREASED 2 0.0008
210 BLOOD CHLORIDE DECREASED 2 0.0008
211 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
212 FAECES HARD 3 0.0008
213 EYE DISCHARGE 8 0.0008
214 EXOSTOSIS 7 0.0008
215 PROSTATOMEGALY 3 0.0008
216 NAIL DISCOLOURATION 3 0.0008
217 EXFOLIATIVE RASH 2 0.0008
218 NERVE COMPRESSION 7 0.0008
219 BLOOD ALBUMIN DECREASED 6 0.0008
220 ERYTHEMA MULTIFORME 7 0.0007
221 SKIN ULCER 19 0.0007
222 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
223 ONYCHOCLASIS 5 0.0007
224 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
225 MACULE 2 0.0007
226 LIVE BIRTH 6 0.0007
227 DERMATITIS 15 0.0007
228 WOUND 20 0.0007
229 DERMATITIS ALLERGIC 9 0.0007
230 GLOSSODYNIA 16 0.0007
231 ELECTRIC SHOCK SENSATION 2 0.0007
232 PULMONARY TOXICITY 5 0.0007
233 CHOLECYSTITIS ACUTE 4 0.0007
234 UTERINE HAEMORRHAGE 3 0.0007
235 NEUTROPHILIA 4 0.0007
236 HEART VALVE INCOMPETENCE 2 0.0007
237 BLOOD MAGNESIUM DECREASED 6 0.0007
238 HEPATIC LESION 3 0.0007
239 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
240 DYSPNOEA AT REST 2 0.0007
241 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
242 ESCHERICHIA SEPSIS 2 0.0007
243 HAND DEFORMITY 9 0.0007
244 DIVERTICULUM INTESTINAL 3 0.0007
245 NAIL DISORDER 6 0.0007
246 LUMBAR SPINAL STENOSIS 2 0.0007
247 MOUTH HAEMORRHAGE 5 0.0007
248 ABDOMINAL ABSCESS 3 0.0007
249 PHYSICAL DISABILITY 3 0.0007
250 HYPOPHOSPHATAEMIA 5 0.0007
251 BLOOD BILIRUBIN INCREASED 18 0.0007
252 SKIN FISSURES 13 0.0007
253 TYPE 1 DIABETES MELLITUS 4 0.0007
254 SUSPECTED OFF LABEL USE 3 0.0007
255 LUPUS-LIKE SYNDROME 6 0.0007
256 HIP ARTHROPLASTY 10 0.0007
257 BLOOD THYROID STIMULATING HORMONE INCREASED 6 0.0007
258 CHOLANGITIS 4 0.0006
259 HYPOALBUMINAEMIA 5 0.0006
260 YELLOW SKIN 3 0.0006
261 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
262 EOSINOPHILIC PNEUMONIA 2 0.0006
263 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
264 NON-CARDIAC CHEST PAIN 2 0.0006
265 STOMATITIS 38 0.0006
266 ENTERITIS 4 0.0006
267 LOWER LIMB FRACTURE 12 0.0006
268 PNEUMONITIS 17 0.0006
269 FIBROMYALGIA 15 0.0006
270 HERPES SIMPLEX 4 0.0006
271 HORMONE LEVEL ABNORMAL 3 0.0006
272 RENAL CELL CARCINOMA 3 0.0006
273 HEPATIC NEOPLASM 2 0.0006
274 METASTASES TO LUNG 7 0.0006
275 PROTEIN URINE PRESENT 3 0.0006
276 TOXIC ENCEPHALOPATHY 3 0.0006
277 HEPATIC CYST 2 0.0006
278 ENDOCARDITIS 3 0.0006
279 NEPHROTIC SYNDROME 4 0.0006
280 VARICOSE VEIN 3 0.0006
281 ORAL PAIN 13 0.0006
282 IMPAIRED HEALING 19 0.0006
283 BLOOD CREATININE ABNORMAL 2 0.0006
284 ENCEPHALITIS 4 0.0006
285 ARTHROPATHY 32 0.0006
286 AUTOIMMUNE HEPATITIS 4 0.0006
287 MUCOSAL INFLAMMATION 15 0.0006
288 FEBRILE NEUTROPENIA 38 0.0006
289 LOWER RESPIRATORY TRACT INFECTION 26 0.0006
290 ERYTHEMA NODOSUM 2 0.0006
291 SPINAL OSTEOARTHRITIS 5 0.0006
292 POLYARTHRITIS 3 0.0006
293 HYPONATRAEMIA 32 0.0006
294 PAPULE 4 0.0006
295 JOINT DISLOCATION 6 0.0006
296 JAUNDICE CHOLESTATIC 2 0.0006
297 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
298 MACULOPATHY 2 0.0006
299 ILEUS 7 0.0006
300 IRRITABLE BOWEL SYNDROME 12 0.0006
301 HAEMATOCRIT DECREASED 11 0.0006
302 BONE LESION 2 0.0006
303 CHEILITIS 3 0.0006
304 ABDOMINAL PAIN LOWER 14 0.0006
305 PRESCRIBED UNDERDOSE 11 0.0006
306 UTERINE LEIOMYOMA 4 0.0005
307 SKIN LESION 15 0.0005
308 FOOD INTOLERANCE 2 0.0005
309 ASTHENOPIA 3 0.0005
310 RED BLOOD CELL SEDIMENTATION RATE INCREASED 6 0.0005
311 UROSEPSIS 5 0.0005
312 BLOOD GLUCOSE ABNORMAL 10 0.0005
313 GASTRIC ULCER HAEMORRHAGE 3 0.0005
314 FOOT DEFORMITY 6 0.0005
315 NEURODERMATITIS 2 0.0005
316 INTERMENSTRUAL BLEEDING 3 0.0005
317 PERICARDITIS 9 0.0005
318 SQUAMOUS CELL CARCINOMA 5 0.0005
319 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
320 CLAVICLE FRACTURE 2 0.0005
321 PARANOIA 9 0.0005
322 SKIN ATROPHY 3 0.0005
323 GINGIVAL DISORDER 2 0.0005
324 BLOOD URIC ACID INCREASED 3 0.0005
325 OSTEOARTHRITIS 22 0.0005
326 CELLULITIS 26 0.0005
327 BLOOD CHOLESTEROL INCREASED 24 0.0005
328 PHARYNGEAL SWELLING 5 0.0005
329 SKIN EXFOLIATION 43 0.0005
330 LYMPHOCYTE COUNT DECREASED 9 0.0005
331 HEPATIC FUNCTION ABNORMAL 19 0.0005
332 HYPOPHAGIA 13 0.0005
333 DRUG ERUPTION 9 0.0005
334 HYPERLIPIDAEMIA 6 0.0005
335 OESOPHAGEAL CANDIDIASIS 2 0.0005
336 SYNOVITIS 9 0.0005
337 BLOOD POTASSIUM DECREASED 15 0.0005
338 HYPOKALAEMIA 23 0.0005
339 OEDEMA 27 0.0005
340 PLATELET COUNT ABNORMAL 3 0.0005
341 INJECTION SITE VESICLES 3 0.0005
342 MYASTHENIA GRAVIS 4 0.0005
343 PSORIATIC ARTHROPATHY 20 0.0005
344 POLYURIA 4 0.0005
345 BLOOD ALKALINE PHOSPHATASE INCREASED 12 0.0005
346 ACUTE CORONARY SYNDROME 4 0.0005
347 DECREASED APPETITE 111 0.0005
348 BLOOD SODIUM DECREASED 9 0.0005
349 ONYCHOMADESIS 2 0.0005
350 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
351 TYPE 2 DIABETES MELLITUS 16 0.0005
352 SENSATION OF FOREIGN BODY 4 0.0005
353 SKIN PLAQUE 4 0.0005
354 HYPOTHYROIDISM 15 0.0005
355 PULMONARY FIBROSIS 9 0.0005
356 INTERVERTEBRAL DISC DISORDER 2 0.0005
357 PROCTALGIA 3 0.0005
358 HAEMOGLOBIN ABNORMAL 3 0.0005
359 NEUTROPHIL COUNT DECREASED 19 0.0005
360 SKIN HYPERPIGMENTATION 4 0.0005
361 ORTHOSTATIC HYPOTENSION 8 0.0005
362 WALKING AID USER 3 0.0005
363 GRIP STRENGTH DECREASED 4 0.0005
364 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
365 CATHETERISATION CARDIAC 2 0.0005
366 CYTOKINE RELEASE SYNDROME 9 0.0004
367 ILEUS PARALYTIC 2 0.0004
368 MALNUTRITION 5 0.0004
369 BREAST MASS 3 0.0004
370 MYOSITIS 4 0.0004
371 THERAPY NON-RESPONDER 20 0.0004
372 FREQUENT BOWEL MOVEMENTS 12 0.0004
373 DRUG EFFECT DELAYED 2 0.0004
374 GINGIVAL BLEEDING 6 0.0004
375 MYOCARDIAL ISCHAEMIA 5 0.0004
376 SCAB 5 0.0004
377 INCREASED TENDENCY TO BRUISE 4 0.0004
378 EYE OPERATION 2 0.0004
379 LYMPHOEDEMA 3 0.0004
380 ARTHRITIS INFECTIVE 2 0.0004
381 DEFAECATION URGENCY 3 0.0004
382 FLANK PAIN 4 0.0004
383 HEPATIC CIRRHOSIS 8 0.0004
384 DUODENAL ULCER 3 0.0004
385 DYSPNOEA EXERTIONAL 16 0.0004
386 BLOOD IRON DECREASED 5 0.0004
387 NEUTROPENIC SEPSIS 3 0.0004
388 FAECAL INCONTINENCE 2 0.0004
389 ATELECTASIS 4 0.0004
390 GASTROENTERITIS 6 0.0004
391 ORAL DISORDER 3 0.0004
392 LIVER INJURY 10 0.0004
393 SENSITIVE SKIN 3 0.0004
394 SMALL INTESTINAL OBSTRUCTION 5 0.0004
395 BREATH SOUNDS ABNORMAL 2 0.0004
396 LIGAMENT SPRAIN 4 0.0004
397 FOOT OPERATION 2 0.0004
398 DIABETIC NEUROPATHY 2 0.0004
399 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
400 PHARYNGITIS 5 0.0004
401 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
402 ERYSIPELAS 2 0.0004
403 ECONOMIC PROBLEM 6 0.0004
404 OSTEOPENIA 6 0.0004
405 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
406 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
407 CHRONIC KIDNEY DISEASE 30 0.0004
408 TOOTH ABSCESS 4 0.0004
409 AMMONIA INCREASED 2 0.0004
410 LIPASE INCREASED 3 0.0004
411 GOUT 7 0.0004
412 SKIN DISORDER 13 0.0004
413 ATRIOVENTRICULAR BLOCK 3 0.0004
414 APHTHOUS ULCER 3 0.0004
415 DIPLOPIA 10 0.0004
416 PANIC ATTACK 14 0.0004
417 ROAD TRAFFIC ACCIDENT 16 0.0004
418 HEPATIC ENZYME INCREASED 26 0.0004
419 DYSURIA 14 0.0004
420 NASAL DISCOMFORT 3 0.0004
421 GINGIVAL PAIN 3 0.0004
422 NYSTAGMUS 2 0.0004
423 PERIPHERAL SWELLING 58 0.0004
424 ABDOMINAL DISCOMFORT 63 0.0004
425 METABOLIC ACIDOSIS 12 0.0004
426 ASCITES 11 0.0004
427 OBSESSIVE-COMPULSIVE DISORDER 3 0.0004
428 NEOPLASM PROGRESSION 13 0.0004
429 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
430 FOOD POISONING 2 0.0004
431 SENSORY LOSS 3 0.0004
432 ACUTE KIDNEY INJURY 57 0.0004
433 OVERWEIGHT 2 0.0004
434 STENT PLACEMENT 3 0.0004
435 ANAL ABSCESS 2 0.0004
436 BLOOD POTASSIUM INCREASED 6 0.0004
437 GASTRIC ULCER 7 0.0004
438 HYPERTENSION 78 0.0004
439 SEPTIC SHOCK 16 0.0004
440 IMPAIRED GASTRIC EMPTYING 5 0.0004
441 HICCUPS 3 0.0004
442 WOUND INFECTION 4 0.0004
443 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
444 SPINAL COMPRESSION FRACTURE 3 0.0004
445 MENSTRUAL DISORDER 3 0.0004
446 ALANINE AMINOTRANSFERASE INCREASED 22 0.0004
447 ASPARTATE AMINOTRANSFERASE INCREASED 19 0.0004
448 ANGIOPATHY 2 0.0004
449 SKIN INFECTION 4 0.0004
450 BLISTER 20 0.0004
451 MITRAL VALVE INCOMPETENCE 4 0.0004
452 PSORIASIS 46 0.0004
453 HEPATITIS 9 0.0004
454 GRANULOCYTOPENIA 2 0.0004
455 VITAMIN D DECREASED 3 0.0004
456 SKIN DISCOLOURATION 16 0.0003
457 MUSCLE TWITCHING 8 0.0003
458 MUSCLE STRAIN 3 0.0003
459 HYPERTHYROIDISM 5 0.0003
460 FEEDING DISORDER 7 0.0003
461 SWELLING 32 0.0003
462 DECREASED INTEREST 2 0.0003
463 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 2 0.0003
464 SKIN HAEMORRHAGE 5 0.0003
465 BACTERAEMIA 4 0.0003
466 OEDEMA PERIPHERAL 41 0.0003
467 CHOLECYSTITIS 4 0.0003
468 CARDIAC PACEMAKER INSERTION 2 0.0003
469 POLYNEUROPATHY 4 0.0003
470 HEPATIC FAILURE 10 0.0003
471 LEUKOCYTOSIS 6 0.0003
472 DRUG INTOLERANCE 32 0.0003
473 BURSITIS 4 0.0003
474 INGUINAL HERNIA 2 0.0003
475 PLATELET COUNT DECREASED 35 0.0003
476 EPILEPSY 10 0.0003
477 PNEUMONIA BACTERIAL 3 0.0003
478 DYSPHAGIA 31 0.0003
479 IRON DEFICIENCY ANAEMIA 3 0.0003
480 UPPER RESPIRATORY TRACT INFECTION 15 0.0003
481 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
482 BREAST CANCER STAGE I 3 0.0003
483 FAECES DISCOLOURED 7 0.0003
484 HAIR COLOUR CHANGES 4 0.0003
485 APPENDICITIS 3 0.0003
486 THERAPY PARTIAL RESPONDER 5 0.0003
487 BASAL CELL CARCINOMA 5 0.0003
488 SWOLLEN TONGUE 10 0.0003
489 BRAIN FOG 5 0.0003
490 PROTEINURIA 6 0.0003
491 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
492 TRANSAMINASES INCREASED 7 0.0003
493 MALIGNANT NEOPLASM PROGRESSION 32 0.0003
494 SLEEP DISORDER 22 0.0003
495 ROTATOR CUFF SYNDROME 4 0.0003
496 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
497 LIVER FUNCTION TEST ABNORMAL 9 0.0003
498 HAEMORRHOIDS 6 0.0003
499 JOINT STIFFNESS 8 0.0003
500 PHOTOSENSITIVITY REACTION 5 0.0003
501 PERICARDIAL EFFUSION 7 0.0003
502 HYPERGLYCAEMIA 11 0.0003
503 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
504 INFUSION RELATED REACTION 20 0.0003
505 APPETITE DISORDER 2 0.0003
506 DIARRHOEA 194 0.0003
507 OVARIAN CYST 3 0.0003
508 URINARY RETENTION 10 0.0003
509 PREGNANCY 6 0.0003
510 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
511 MALIGNANT MELANOMA 4 0.0003
512 TOXIC SKIN ERUPTION 3 0.0003
513 HYPOTHERMIA 3 0.0003
514 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
515 ABNORMAL LOSS OF WEIGHT 2 0.0003
516 LIVER DISORDER 13 0.0003
517 EAR DISCOMFORT 3 0.0003
518 DRY SKIN 39 0.0003
519 BLOOD PRESSURE FLUCTUATION 7 0.0003
520 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
521 TEMPERATURE INTOLERANCE 3 0.0003
522 COLITIS 11 0.0003
523 HYPERTRANSAMINASAEMIA 2 0.0003
524 CEREBRAL INFARCTION 7 0.0003
525 CARPAL TUNNEL SYNDROME 4 0.0003
526 INTENTIONAL PRODUCT USE ISSUE 25 0.0003
527 NEUROTOXICITY 5 0.0003
528 METASTASES TO LIVER 5 0.0003
529 HALLUCINATION, VISUAL 6 0.0003
530 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
531 DRY MOUTH 23 0.0003
532 SEASONAL ALLERGY 4 0.0003
533 SYSTEMIC LUPUS ERYTHEMATOSUS 10 0.0003
534 DRY EYE 14 0.0003
535 METASTASIS 2 0.0003
536 CEREBRAL HAEMORRHAGE 10 0.0003
537 POOR QUALITY SLEEP 6 0.0003
538 MOBILITY DECREASED 20 0.0003
539 ADVERSE DRUG REACTION 25 0.0003
540 ANAEMIA 53 0.0003
541 TOOTHACHE 5 0.0003
542 OSTEOMYELITIS 5 0.0003
543 INTENTIONAL PRODUCT MISUSE 24 0.0003
544 DYSPHONIA 16 0.0003
545 SINUSITIS 28 0.0003
546 STEVENS-JOHNSON SYNDROME 6 0.0003
547 TOOTH DISORDER 6 0.0003
548 INTERSTITIAL LUNG DISEASE 13 0.0003
549 COLON CANCER 4 0.0003
550 OSTEOPOROSIS 11 0.0003
551 INTESTINAL PERFORATION 3 0.0003
552 OCULAR DISCOMFORT 3 0.0003
553 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
554 REBOUND EFFECT 3 0.0003
555 BLOOD URINE PRESENT 5 0.0003
556 EAR INFECTION 7 0.0003
557 HAEMATURIA 9 0.0003
558 SLEEP APNOEA SYNDROME 5 0.0003
559 HYPERTHERMIA 2 0.0003
560 SKIN IRRITATION 12 0.0003
561 PAIN IN EXTREMITY 77 0.0003
562 RASH 113 0.0003
563 LIMB DISCOMFORT 8 0.0003
564 ABDOMINAL PAIN 60 0.0003
565 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
566 ACUTE MYELOID LEUKAEMIA 4 0.0003
567 SPLENOMEGALY 3 0.0003
568 GASTROINTESTINAL INFLAMMATION 2 0.0003
569 DRUG-INDUCED LIVER INJURY 8 0.0003
570 AFFECTIVE DISORDER 2 0.0003
571 COVID-19 PNEUMONIA 3 0.0003
572 PNEUMOTHORAX 4 0.0003
573 ABSCESS 4 0.0003
574 PANCYTOPENIA 14 0.0003
575 WRIST FRACTURE 3 0.0003
576 CONTUSION 24 0.0002
577 THYROID CANCER 3 0.0002
578 BLOOD PRESSURE INCREASED 38 0.0002
579 NIGHT SWEATS 8 0.0002
580 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
581 NOCTURIA 3 0.0002
582 DISCOMFORT 15 0.0002
583 PYREXIA 85 0.0002
584 DECUBITUS ULCER 2 0.0002
585 HYPERAESTHESIA 2 0.0002
586 ESCHERICHIA INFECTION 2 0.0002
587 SEPSIS 27 0.0002
588 GENERAL PHYSICAL HEALTH DETERIORATION 28 0.0002
589 WEIGHT DECREASED 67 0.0002
590 RHABDOMYOLYSIS 10 0.0002
591 SECRETION DISCHARGE 3 0.0002
592 FATIGUE 186 0.0002
593 BLOOD UREA INCREASED 4 0.0002
594 HAEMODIALYSIS 2 0.0002
595 EYE PRURITUS 8 0.0002
596 FACE OEDEMA 4 0.0002
597 CONDITION AGGRAVATED 72 0.0002
598 DISEASE PROGRESSION 28 0.0002
599 RENAL INJURY 7 0.0002
600 JOINT INJURY 5 0.0002
601 DRUG RESISTANCE 6 0.0002
602 RENAL FAILURE 31 0.0002
603 INFLAMMATION 12 0.0002
604 DEHYDRATION 31 0.0002
605 MUSCULOSKELETAL DISCOMFORT 4 0.0002
606 JOINT SWELLING 28 0.0002
607 HIATUS HERNIA 3 0.0002
608 INJECTION SITE INDURATION 3 0.0002
609 NEUROPATHY PERIPHERAL 22 0.0002
610 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
611 THERAPEUTIC RESPONSE DECREASED 14 0.0002
612 DELIRIUM 8 0.0002
613 PLATELET COUNT INCREASED 3 0.0002
614 ALOPECIA 45 0.0002
615 BLOOD CALCIUM INCREASED 2 0.0002
616 ADVERSE EVENT 21 0.0002
617 DISORIENTATION 9 0.0002
618 LUNG INFILTRATION 2 0.0002
619 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
620 LYMPHADENOPATHY 8 0.0002
621 VOMITING 106 0.0002
622 RASH MACULO-PAPULAR 5 0.0002
623 HEPATOTOXICITY 5 0.0002
624 JOINT RANGE OF MOTION DECREASED 3 0.0002
625 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
626 GASTROINTESTINAL DISORDER 20 0.0002
627 CONFUSIONAL STATE 36 0.0002
628 ANAL INCONTINENCE 2 0.0002
629 SINUS CONGESTION 3 0.0002
630 OROPHARYNGEAL DISCOMFORT 2 0.0002
631 HEAD INJURY 7 0.0002
632 PALLOR 6 0.0002
633 ERYTHEMA 45 0.0002
634 ABDOMINAL PAIN UPPER 45 0.0002
635 URINARY TRACT INFECTION 37 0.0002
636 POLLAKIURIA 9 0.0002
637 HAEMOPTYSIS 6 0.0002
638 COORDINATION ABNORMAL 3 0.0002
639 NECK PAIN 12 0.0002
640 BACTERIAL INFECTION 4 0.0002
641 HYPOTENSION 43 0.0002
642 HAEMOGLOBIN DECREASED 22 0.0002
643 COGNITIVE DISORDER 10 0.0002
644 ILL-DEFINED DISORDER 13 0.0002
645 PLEURAL EFFUSION 13 0.0002
646 SKIN REACTION 3 0.0002
647 LACERATION 2 0.0002
648 ARTERIOSCLEROSIS 2 0.0002
649 LYMPHOPENIA 3 0.0002
650 ABDOMINAL DISTENSION 22 0.0002
651 HAEMATOTOXICITY 2 0.0002
652 ECZEMA 11 0.0002
653 RED BLOOD CELL COUNT DECREASED 6 0.0002
654 INCREASED APPETITE 4 0.0002
655 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
656 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
657 ASTHENIA 78 0.0002
658 HYPOAESTHESIA 31 0.0002
659 HERNIA 4 0.0002
660 EAR PAIN 4 0.0002
661 PRURITUS 79 0.0002
662 NAUSEA 162 0.0002
663 ARTHRALGIA 85 0.0002
664 DRUG ABUSE 17 0.0002
665 LUNG DISORDER 10 0.0002
666 GAIT DISTURBANCE 39 0.0002
667 ENCEPHALOPATHY 5 0.0002
668 ANGIOEDEMA 9 0.0002
669 KNEE OPERATION 2 0.0002
670 BODY TEMPERATURE DECREASED 2 0.0002
671 MUSCULAR WEAKNESS 23 0.0002
672 DISABILITY 4 0.0002
673 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
674 CONSTIPATION 44 0.0002
675 INABILITY TO AFFORD MEDICATION 2 0.0002
676 HYPERKALAEMIA 7 0.0002
677 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0002
678 FULL BLOOD COUNT DECREASED 4 0.0002
679 TINNITUS 9 0.0002
680 NEUTROPHIL COUNT INCREASED 2 0.0002
681 EYE PAIN 11 0.0002
682 DEVICE RELATED INFECTION 3 0.0002
683 THYROID DISORDER 3 0.0002
684 OROPHARYNGEAL PAIN 18 0.0002
685 MUSCULOSKELETAL STIFFNESS 17 0.0002
686 FLATULENCE 11 0.0002
687 MUSCULOSKELETAL CHEST PAIN 3 0.0002
688 HYPERBILIRUBINAEMIA 2 0.0002
689 RESPIRATORY TRACT INFECTION 5 0.0002
690 BONE DENSITY DECREASED 6 0.0002
691 ANHEDONIA 5 0.0002
692 GASTRITIS 5 0.0002
693 MOUTH ULCERATION 4 0.0002
694 FULL BLOOD COUNT ABNORMAL 2 0.0002
695 CHEST PAIN 35 0.0002
696 RASH ERYTHEMATOUS 9 0.0002
697 RETCHING 4 0.0002
698 CARDIAC FAILURE 15 0.0002
699 BREAST CANCER METASTATIC 2 0.0002
700 PRODUCT USE IN UNAPPROVED INDICATION 46 0.0002
701 PNEUMONIA 60 0.0002
702 OFF LABEL USE 162 0.0002
703 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
704 BACK DISORDER 3 0.0002
705 BIPOLAR DISORDER 2 0.0002
706 DENTAL CARIES 2 0.0002
707 DIZZINESS 90 0.0002
708 FUNGAL INFECTION 6 0.0002
709 FEELING COLD 5 0.0002
710 WEIGHT INCREASED 40 0.0002
711 ARTHRITIS 14 0.0002
712 FISTULA 2 0.0002
713 BLOOD CALCIUM DECREASED 2 0.0002
714 HEMIPARESIS 3 0.0002
715 DYSPNOEA 100 0.0002
716 MYALGIA 30 0.0002
717 CIRCULATORY COLLAPSE 3 0.0002
718 DERMATITIS CONTACT 2 0.0002
719 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
720 MICTURITION URGENCY 2 0.0002
721 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
722 EPISTAXIS 13 0.0002
723 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
724 LOCAL SWELLING 3 0.0002
725 RASH MACULAR 6 0.0002
726 HEART RATE DECREASED 6 0.0002
727 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
728 DEPRESSED MOOD 9 0.0002
729 COLD SWEAT 3 0.0002
730 ACUTE MYOCARDIAL INFARCTION 5 0.0002
731 DEEP VEIN THROMBOSIS 11 0.0002
732 BLOOD CREATININE INCREASED 11 0.0002
733 GALLBLADDER DISORDER 3 0.0002
734 PRODUCT PRESCRIBING ERROR 4 0.0002
735 COUGH 47 0.0002
736 MUSCLE RIGIDITY 2 0.0002
737 RENAL IMPAIRMENT 14 0.0002
738 GASTROENTERITIS VIRAL 3 0.0002
739 LOCALISED INFECTION 4 0.0002
740 PELVIC PAIN 3 0.0002
741 RESTLESS LEGS SYNDROME 3 0.0002
742 NEURALGIA 4 0.0002
743 AGITATION 12 0.0002
744 HAEMATOCHEZIA 9 0.0002
745 PAIN 100 0.0002
746 MUSCLE SPASTICITY 2 0.0002
747 HYPERCALCAEMIA 2 0.0002
748 BALANCE DISORDER 14 0.0002
749 MEDICATION ERROR 9 0.0002
750 OSTEONECROSIS OF JAW 4 0.0002
751 HYPERSENSITIVITY 30 0.0002
752 THROMBOSIS 13 0.0002
753 VISUAL IMPAIRMENT 20 0.0002
754 NERVOUS SYSTEM DISORDER 5 0.0002
755 MEMORY IMPAIRMENT 22 0.0002
756 INJECTION SITE DISCOLOURATION 2 0.0002
757 LEUKOPENIA 8 0.0002
758 PRODUCT DOSE OMISSION ISSUE 47 0.0002
759 HALLUCINATION 12 0.0002
760 SOMNOLENCE 32 0.0002
761 INFECTION 23 0.0002
762 MUSCULOSKELETAL DISORDER 3 0.0002
763 CYSTITIS 5 0.0002
764 HERPES ZOSTER 9 0.0002
765 INJURY 11 0.0002
766 LETHARGY 9 0.0002
767 DRUG PRESCRIBING ERROR 3 0.0002
768 ACUTE RESPIRATORY FAILURE 3 0.0002
769 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
770 INFUSION SITE PAIN 2 0.0002
771 ERUCTATION 3 0.0002
772 SWELLING FACE 10 0.0002
773 NODULE 2 0.0002
774 KIDNEY INFECTION 3 0.0002
775 MUSCULOSKELETAL PAIN 8 0.0002
776 NEPHROLITHIASIS 7 0.0002
777 OSTEONECROSIS 5 0.0002
778 THROMBOCYTOPENIA 17 0.0002
779 ORAL CANDIDIASIS 2 0.0002
780 DERMATITIS ATOPIC 8 0.0002
781 SINUS DISORDER 3 0.0002
782 CATARACT 9 0.0002
783 LIP SWELLING 5 0.0001
784 HAIR TEXTURE ABNORMAL 2 0.0001
785 JAUNDICE 4 0.0001
786 HEADACHE 93 0.0001
787 DYSGEUSIA 11 0.0001
788 ANXIETY 42 0.0001
789 LIMB INJURY 4 0.0001
790 FALL 49 0.0001
791 NEUTROPENIA 20 0.0001
792 PRODUCTIVE COUGH 7 0.0001
793 CHEST DISCOMFORT 15 0.0001
794 NASOPHARYNGITIS 27 0.0001
795 BACK PAIN 34 0.0001
796 CORONARY ARTERY OCCLUSION 2 0.0001
797 BLOOD GLUCOSE DECREASED 7 0.0001
798 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
799 CHILLS 17 0.0001
800 RESPIRATORY DISTRESS 4 0.0001
801 ANAPHYLACTIC REACTION 8 0.0001
802 DIABETES MELLITUS 11 0.0001
803 ORAL DISCOMFORT 2 0.0001
804 BLOOD TEST ABNORMAL 2 0.0001
805 IMPAIRED WORK ABILITY 3 0.0001
806 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
807 LIVER FUNCTION TEST INCREASED 3 0.0001
808 RECTAL HAEMORRHAGE 6 0.0001
809 SKIN CANCER 3 0.0001
810 MYELODYSPLASTIC SYNDROME 2 0.0001
811 HYPOKINESIA 2 0.0001
812 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
813 PULMONARY EMBOLISM 13 0.0001
814 BONE PAIN 8 0.0001
815 SURGERY 8 0.0001
816 MELAENA 3 0.0001
817 MUSCLE SPASMS 25 0.0001
818 BLOOD PRESSURE DECREASED 9 0.0001
819 INSOMNIA 36 0.0001
820 BRONCHITIS 10 0.0001
821 TACHYCARDIA 12 0.0001
822 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
823 WHEEZING 8 0.0001
824 PULMONARY OEDEMA 6 0.0001
825 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
826 CHROMATURIA 3 0.0001
827 ASTHMA 15 0.0001
828 HOT FLUSH 10 0.0001
829 HYPOAESTHESIA ORAL 2 0.0001
830 LACRIMATION INCREASED 4 0.0001
831 APPLICATION SITE PRURITUS 3 0.0001
832 VERTIGO 8 0.0001
833 SHOCK 3 0.0001
834 MALAISE 57 0.0001
835 DISTURBANCE IN ATTENTION 7 0.0001
836 RASH PRURITIC 7 0.0001
837 DELUSION 2 0.0001
838 LUNG INFECTION 2 0.0001
839 EJECTION FRACTION DECREASED 2 0.0001
840 PALPITATIONS 15 0.0001
841 PRODUCT USE ISSUE 24 0.0001
842 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
843 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
844 CARDIAC FAILURE CONGESTIVE 10 0.0001
845 HYPOGLYCAEMIA 6 0.0001
846 PRESYNCOPE 3 0.0001
847 RHEUMATOID ARTHRITIS 14 0.0001
848 ATRIAL FIBRILLATION 12 0.0001
849 AMNESIA 8 0.0001
850 CHOLELITHIASIS 4 0.0001
851 METASTASES TO BONE 2 0.0001
852 MULTIPLE FRACTURES 2 0.0001
853 STAPHYLOCOCCAL INFECTION 4 0.0001
854 TREATMENT FAILURE 10 0.0001
855 VISUAL ACUITY REDUCED 4 0.0001
856 CYTOMEGALOVIRUS INFECTION 2 0.0001
857 AGEUSIA 3 0.0001
858 SUICIDAL IDEATION 11 0.0001
859 PNEUMONIA ASPIRATION 3 0.0001
860 SYNCOPE 12 0.0001
861 URTICARIA 20 0.0001
862 ACNE 9 0.0001
863 FLUID RETENTION 6 0.0001
864 RENAL FAILURE ACUTE 5 0.0001
865 INFLUENZA 13 0.0001
866 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 21 0.0001
867 ILLNESS 12 0.0001
868 HAEMATOMA 3 0.0001
869 MULTI-ORGAN FAILURE 2 0.0001
870 VAGINAL HAEMORRHAGE 5 0.0001
871 DEAFNESS 3 0.0001
872 TREMOR 19 0.0001
873 PARAESTHESIA 18 0.0001
874 DEPRESSION 26 0.0001
875 HYPOXIA 4 0.0001
876 PANCREATITIS 6 0.0001
877 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
878 HEAD DISCOMFORT 2 0.0001
879 THERAPY INTERRUPTED 8 0.0001
880 BONE DISORDER 2 0.0001
881 HYPERHIDROSIS 14 0.0001
882 RHINORRHOEA 7 0.0001
883 COVID-19 19 0.0001
884 PROCEDURAL PAIN 3 0.0001
885 MENTAL STATUS CHANGES 3 0.0001
886 CONJUNCTIVITIS 2 0.0001
887 AGRANULOCYTOSIS 2 0.0001
888 HEPATIC STEATOSIS 2 0.0001
889 OXYGEN SATURATION DECREASED 6 0.0001
890 FRACTURE 2 0.0001
891 MULTIPLE SCLEROSIS 5 0.0001
892 FEELING ABNORMAL 25 0.0001
893 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
894 CHOLESTASIS 2 0.0001
895 DYSSTASIA 3 0.0001
896 DYSPEPSIA 10 0.0001
897 URINARY INCONTINENCE 3 0.0001
898 RESPIRATORY DISORDER 3 0.0001
899 BURNING SENSATION 7 0.0001
900 PREMATURE BABY 3 0.0001
901 APHASIA 3 0.0001
902 SKIN BURNING SENSATION 7 0.0001
903 INFLUENZA LIKE ILLNESS 8 0.0001
904 FEMUR FRACTURE 3 0.0001
905 NERVOUSNESS 5 0.0001
906 BLOOD GLUCOSE INCREASED 18 0.0001
907 MOOD SWINGS 3 0.0001
908 EATING DISORDER 2 0.0001
909 LOSS OF CONSCIOUSNESS 12 0.0001
910 HYPOACUSIS 4 0.0001
911 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
912 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
913 APPLICATION SITE PAIN 2 0.0001
914 VIRAL INFECTION 3 0.0001
915 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
916 COLITIS ULCERATIVE 4 0.0001
917 OVERDOSE 19 0.0001
918 INJECTION SITE BRUISING 7 0.0001
919 DRUG INEFFECTIVE 115 0.0001
920 DRUG DEPENDENCE 14 0.0001
921 NASAL CONGESTION 5 0.0001
922 INJECTION SITE PAIN 26 0.0001
923 ARRHYTHMIA 4 0.0001
924 OCULAR HYPERAEMIA 4 0.0001
925 DISEASE RECURRENCE 4 0.0001
926 MIGRAINE 8 0.0001
927 MYELOSUPPRESSION 3 0.0001
928 DIABETIC KETOACIDOSIS 2 0.0001
929 DRUG EFFECT INCOMPLETE 3 0.0001
930 UNDERDOSE 6 0.0001
931 HEART RATE INCREASED 8 0.0001
932 INTESTINAL OBSTRUCTION 3 0.0001
933 HAEMATEMESIS 2 0.0001
934 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
935 HAEMORRHAGE 8 0.0001
936 BRADYCARDIA 4 0.0001
937 BREAST CANCER FEMALE 2 0.0001
938 CARDIAC DISORDER 7 0.0001
939 EMOTIONAL DISTRESS 9 0.0001
940 TREATMENT NONCOMPLIANCE 4 0.0001
941 VISION BLURRED 10 0.0001
942 DIVERTICULITIS 2 0.0001
943 DEMENTIA 2 0.0001
944 INTENTIONAL DOSE OMISSION 2 0.0001
945 ANGINA PECTORIS 2 0.0001
946 HYPERSOMNIA 2 0.0001
947 SEIZURE 8 0.0001
948 MENTAL DISORDER 3 0.0001
949 NEEDLE ISSUE 2 0.0001
950 LABORATORY TEST ABNORMAL 2 0.0001
951 THROAT IRRITATION 3 0.0001
952 CORONARY ARTERY DISEASE 2 0.0001
953 FEELING HOT 4 0.0001
954 HOSPITALISATION 10 0.0001
955 RENAL DISORDER 3 0.0001
956 COLORECTAL CANCER 3 0.0001
957 DEATH 53 0.0001
958 EYE DISORDER 2 0.0001
959 CARDIAC ARREST 5 0.0001
960 INJECTION SITE PRURITUS 4 0.0001
961 FLUSHING 6 0.0001
962 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
963 SPEECH DISORDER 3 0.0001
964 DRUG INTERACTION 9 0.0001
965 DEVICE ISSUE 5 0.0001
966 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
967 RESPIRATORY FAILURE 4 0.0001
968 INJECTION SITE MASS 2 0.0001
969 EYE SWELLING 2 0.0001
970 DYSARTHRIA 2 0.0001
971 UNEVALUABLE EVENT 4 0.0001
972 INCORRECT DOSE ADMINISTERED 12 0.0001
973 CONVULSION 3 0.0001
974 EYE IRRITATION 3 0.0001
975 INJECTION SITE HAEMORRHAGE 4 0.0001
976 IRRITABILITY 3 0.0000
977 EXTRA DOSE ADMINISTERED 2 0.0000
978 DYSKINESIA 2 0.0000
979 MYOCARDIAL INFARCTION 8 0.0000
980 COMA 2 0.0000
981 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
982 INJECTION SITE SWELLING 3 0.0000
983 CEREBROVASCULAR ACCIDENT 6 0.0000
984 INJECTION SITE ERYTHEMA 4 0.0000
985 EXPOSURE DURING PREGNANCY 2 0.0000
986 DRUG DOSE OMISSION 5 0.0000
987 NEOPLASM MALIGNANT 2 0.0000
988 TOXICITY TO VARIOUS AGENTS 5 0.0000
989 INJECTION SITE REACTION 2 0.0000
990 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
991 DRUG DOSE OMISSION BY DEVICE 2 0.0000
992 BREAST CANCER 2 0.0000
993 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
994 NO ADVERSE EVENT 3 0.0000